|
|
 |
For more information on advertising in this newsletter, contact Melba Romero at 210-878-9978 or email to hcbmag@sbcglobal.net |
|
Diversified Employee Benefit Services, LLC |
 |
|
|
| Sign-up today to start receiving
The HCB Newsletter! |
 | |
|
| Welcome!
To San Antonio's newest online healthcare and bioscience community and to The HCB Newsletter, feeder publication to the S.A. HC+B website and the upcoming San Antonio Healthcare & Bioscience Magazine, www.hcbmagazine.com.
This week's issue is chock-full of breaking news and special announcements featuring innovative technologies, people on the move, and other important industry transformations.
Plus! look for exciting information on the upcoming S.A. HC+B E-Magazine with a launch date right around the corner!
Enjoy!
Melba Romero
Publisher/Editor
S.A. Healthcare & Bioscience Magazine |
William L. Henrich Appointed Interim President of UT Health Science Center at San Antonio |
 UT Health Science Center at San Antonio, San Antonio, TX - January 12, 2009
William L. Henrich, M.D., vice president for medical affairs and dean of the School of Medicine at The University of Texas Health Science Center at San Antonio, was named on Monday (Jan. 12) as interim president of the health science center. Henrich will succeed Francisco G. Cigarroa, M.D., who last week was officially named chancellor of the UT System, effective Feb. 2. Full Story. |
|
First Pediatric Patient at CHRISTUS Santa Rosa Children's Hospital (CRSCH) Successfully Receives Kidney Transplant |
 CHRISTUS Santa Rosa Children's Hospital, San Antonio, TX - January 12, 2009
Following several months of planning, CHRISTUS Santa Rosa Children's Hospital has added pediatric solid organ transplantation to its list of high-tech, high-touch services. In collaboration with the UTHSCSA and under the leadership of Dr. Glenn Halff, kidney transplant services are now available as of January 1, 2009. Full Story. |
|
Evestra™ Signs Research Contract With NIH |
 Evestra, Inc., San Antonio, TX - January 12, 2009Evestra™, Inc., today announced it has signed a contract with the National Institutes of Health (NIH) to collaborate on the development of therapeutics focused on unmet needs in reproductive health. The agreement transfers Dr. P.N. Rao's long-standing contract between the NIH and the Southwest Foundation for Biomedical Research (SFBR) to Evestra™, where Rao is now Senior Vice President of Research. He was Senior Scientist and Chairman of the Organic Chemistry Department at the Foundation before it spun off Evestra™ in April 2008. Full Story. |
| BioMedical Enterprises, Inc. (BME), Announces Kenneth I. Moch as its President and Chief Executive Officer |
 BioMedical Enterprises, Inc. (BME), San Antonio, TX - January 7, 2009
BioMedical Enterprises, Inc. (BME), a cutting edge medical device company focused on the development of orthopaedic memory metal implants, announced today that it has appointed Kenneth I. Moch as its President and Chief Executive Officer. W. Casey Fox, PhD, P.E., BME's Founder, will become Chief Technology Officer and continue to focus his efforts on building BME's innovative product offerings. Full Story. |
| Caesarean Section Before 39 Weeks Raises Risk to Infant Lungs, Study Shows |
 The University of Texas Health Science Center at San Antonio, San Antonio, TX - January 9, 2009
For a healthy mother and baby, scheduling a Caesarean section delivery one to two weeks earlier than necessary slightly raises the risk of respiratory and other preventable problems in the newborn, and women should be counseled with this in mind. That's the conclusion of a federally funded study conducted at 19 maternal-fetal medicine sites including The University of Texas Health Science Center at San Antonio. Full Story. |
| Genzyme and Isis Begin New Clinical Trials of Mipomersen |
 Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), January 12, 2009 Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that they have begun two new studies of mipomersen, a novel lipid-lowering drug in late-stage development, and a third is currently screening patients. These three trials will provide additional data on mipomersen in high-risk patient populations. The new studies, together with ongoing trials, will also substantially increase the size of the database of patients treated with mipomersen over the next 18 months. Full Story. |
|
Dr. Jerald Winakur and Hyperion Press Announce Release of New Book |
 MEMORY LESSONS: A Doctor's Story is an honest and courageous account of Dr. Jerald Winakur's father's last years, the life he slowly forgot, and what a family faces when dementia begins destroying memory after memory, ability after ability.
The Center for Medical Humanities & Ethics and Pasteur Medical Associates present: MEMORY LESSONS: A Doctor's StoryJerald Winakur, MD, FACP, CMD Thursday, January 22, 2009, 6:00-7:00 pm Reception and Book Signing: 7:00-8:00 pm UT Health Science Center San Antonio 7703 Floyd Curl Dr., RM. 3.102 (Next to the Briscoe Library) Full Story. | |
|
|
|
